As shown, each of inhibitors maintained the potent activities in inhibiting EG.5.1 cell fusion (Figure 3A), PsV entry in 293T/ACE2, Huh‐7, or Caco‐2 cells (Figure 3C,D), and live virus infection in Vero E6 cells (Figure 3E). This evidence concerns the gene ACE2 and viral infectious disease.